Menopause is a natural aging process causing estrogen deficiency, accelerating atherogenic processes including dyslipidemia. Prevalence of thyroid dysfunction is also high in postmenopausal women, and it is known to elevate the risk of cardiovascular disease (CVD). Therefore, we are to study on the associations in between serum thyroid stimulating hormone (TSH) and prevalence of CVD in postmenopausal women who have normal thyroid function. 
Introduction
Menopause is a status characterized with decrease in estrogen and increase in ferritin levels. As serum estrogen is known to prevent the prevalence of atherosclerosis, postmenopausal women are at high risk of developing cardiovascular disease (CVD). Consequently, CVD including coronary artery disease (CAD) and strokes contribute to have higher morbidity and mortality rates in postmenopausal women. 1 Prevalence of high levels of thyroid stimulating hormone (TSH) increases with age, especially after menopause. Thyroid hormone has both direct and indirect actions on heart and vascular systems. Both hypothyroidism and hyperthyroidism have been studied to cause detrimental effects in cardiovascular system. Also, from previous studies, invasive and noninvasive measurements of thyroid function in women having thyroid disease are known to be closely linked to cardiac functions such as heart rate, cardiac output and systemic vascular resistance. 2 Serum TSH has also been to have positive associations with serum total cholesterol (TC), low-density lipoprotein cholesterol (LDL-C), non-highdensity lipoprotein cholesterol (non-HDL-C), triglycerides (TG) and negative association with serum HDL-C. All statistical analyses were conducted using SPSS ver.
15.0 (SPSS Inc., Chicago, IL, USA). A P value less than 0.05 was considered to be statistically significant.
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Results
Baseline characteristics of the subjects are displayed on were found to have coronary atherosclerosis.
We were to investigate on association in between serum TSH level and clinical variables using simple correlation analysis. Age, TG were weakly positively correlated (r = 0.148, P = 0.020 and r = 0.169, P = 0.008, respectively), and HDL-C was weakly negatively correlated (r = -0.145, P = 0.023) with serum TSH (Table 2 ). Based on these findings, multiple linear regression analysis was done, and it revealed that serum TSH was associated with serum TG (β = 0.146, P = 0.023). Although they were not significant, serum TSH also had tendency to have associations with age and serum HDL-C (Table 3) .
To find factors which independently affect on presence of coronary atherosclerosis, stepwise multiple logistic regression (Table   5 ).
Discussion
The findings of the present study indicate that serum TSH levels could be considered as an independent predictive marker of the presence of coronary atherosclerosis in euthyroid postmenopausal women. Also, serum TSH levels within a normal range may be associated with age and some lipid profiles in these women. These findings suggest that increase in age, TG and decrease in HDL-C levels may be related to TSH elevation, and these changes would lead to higher risk of having coronary atherosclerosis in healthy postmenopausal women.
Menopause is a natural aging process causing estrogen deficiency. In premenopausal period, women have a significantly lower risk for CVD compared to postmenopausal women or age matched men. 4 However, after menopause, decline in serum estrogen accelerates atherogenic processes, including dyslipidemia, endothelial dysfunction, arterial stiffness, and increase the risk for CVD, which threaten women's health. 5 This disparity between prevalence of CVD Prevalence of thyroid dysfunction appears to be high in postmenopausal woman. 12 Thyroid dysfunction is diagnosed by measuring of the serum thyrotropin which is known as TSH, and it is known as the best and the most reliable test to diagnose thyroid disease. 13, 14 Thyroid dysfunction is defined based on clinical signs, symptoms, and serum TSH level. 15 In the Study of Women's Health Across the Nation (SWAN), serum TSH levels outside the normal range were found to be up to 9.4% in women aged from 42 to 52 years old. Also, serum TSH statistically increased in 3.5%, for each 5 years as age increases. 16 Thyroid hormone also increases blood volume. 26 As systemic vascular resistance decreases, the effective arterial filling volume falls, which causes increase in renin secretion and activation of the angiotensin-aldosterone axis. Then, it eventually stimulates renal sodium reabsorption and finally increases plasma volume. 27 Patients with hyperthyroidism mainly have decrease in systemic vascular resistance, and increase in resting heart rate, left ventricular contractility, ejection fraction, and blood volume, which overall increase cardiac output, higher than in normal population. 26, 28 On the other hand, hemodynamic changes in hypothyroidism are opposite to the ones in hyperthyroidism. The usual signs are bradycardia, decrease in ventricular filling with decrease in cardiac contractility causing low cardiac output. 29 Although hypothyroidism presents milder clinical symptoms than hyperthyroidism, it may cause accelerated atherosclerosis and CAD. 30 In one population-based cross-sectional study, subclinical In conclusion, it revealed that significant predictor of serum TSH was serum TG, and increasing age and TSH were found to have associations with an increased risk of coronary atherosclerosis in euthyroid postmenopausal women. As life span is extended in these days, for even in healthy postmenopausal women, screening and risk assessment for CVD and proper management of modifiable risk factors would be required before atherosclerosis develops.
